α-PHP

1. 2026-10-19issueIssued info_card
2. 2026-09-07srcIntoxication cases associated with the novel designer drug 3',4'-methylenedioxy-α-pyrrolidinohexanophenone and studies on its human metabolism using high-resolution mass spectrometry
3. 2026-09-07srcStability of synthetic cathinones in clinical and forensic toxicological analysis—Where are we now?
4. 2026-09-07srcIn vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats
5. 2026-09-07srcEffects of α-pyrrolidino-phenone cathinone stimulants on locomotor behavior in female rats.
6. 2026-09-07srcα-PHP: Acute effects and pharmacokinetic in male and female mice, and clinical data on related intoxications
7. 2026-09-07srcCase series involving the synthetic cathinones alpha-PHP, alpha-PiHP, MDPHP, and MDPiHP in forensic investigations
8. 2026-09-07srcStructure-Activity Relationships for a Recently Controlled Synthetic Cathinone Dopamine Transporter Reuptake Inhibitor: α-Pyrrolidinohexiophenone (α-PHP)
9. 2026-09-07srcPersistent binding at dopamine transporters determines sustained psychostimulant effects
10. 2026-09-07srcFetal death associated with the use of 3,4-MDPHP and α-PHP
11. 2026-09-07srcEffects of α-Pyrrolidinopentiophenone and 4-Methyl-N-Ethylcathinone on Intracranial Self-Stimulation Thresholds in Rats
12. 2026-09-07srcToxicological Investigation of a Case Series Involving the Synthetic Cathinone α-Pyrrolidinohexiophenone (α-PHP) and Identification of Phase I and II Metabolites in Human Urine
13. 2026-09-07srcPolydrug fatal intoxication involving MDPHP: Detection and in silico investigation of multiple 3,4-methylenedioxy-derived designer drugs and their metabolites
14. 2026-09-07srcElimination half-life of alpha-pyrrolidinovalerophenone in an acute non-fatal intoxication
15. 2026-09-07srcSynthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective
16. 2026-09-07srcPyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations
17. 2026-09-07srcEvaluation of Cytotoxic and Mutagenic Effects of the Synthetic Cathinones Mexedrone, α-PVP and α-PHP
18. 2026-09-07srcThe Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.
19. 2026-09-07srcSynthetic Cathinones and Neurotoxicity Risks: A Systematic Review
20. 2026-09-07srcNew Psychoactive Substances Toxicity: A Systematic Review of Acute and Chronic Psychiatric Effects
21. 2026-09-07srcα-Pyrrolidinohexanophenone (α-PHP) and α-Pyrrolidinoisohexanophenone (α-PiHP): A Review
22. 2026-09-07srcSchedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone [et al.] in Schedule I
23. 2026-09-07srcCritical Review Report: alpha-PHP (α-Pyrrolidinohexanophenone) or PV-7
24. 2026-09-04issueIssued emergency
25. 2026-09-04issueIssued info_card
26. 2026-09-04issueIssued notice
27. 2026-06-04proposal58 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
28. 2026-06-04publicationPublication — backfill
29. 2026-05-08revisionRevision 1
30. 2026-05-08absenceSearched ClinicalTrials.gov for "alpha-pyrrolidinohexanophenone synthetic cathinone" — no results
31. 2026-05-08genGeneration — pipeline-v5 · with 2 morepipeline-v5
32. 2026-05-08rungeneration run

The same entries, as forms: six forms.